Company Profile

Company Description

Sutro Biopharma, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative oncology and autoimmune therapeutics. Utilizing its proprietary cell-free protein synthesis platform, XpressCF®, the company designs and manufactures next-generation antibody-drug conjugates (ADCs) and cytokine-based therapies. Its pipeline includes targeted treatments aimed at improving patient outcomes with enhanced efficacy and reduced side effects. The company collaborates with leading pharmaceutical firms to advance its cutting-edge drug candidates through clinical trials.